CSL Biotherapies, and its parent company, CSL Limited have reached an agreement with Merck & Co., Inc. on rights to market and distribute Afluria® in the United States under an exclusive, six-year agreement effective September 3, 2009. Merck has the exclusive right to sell and distribute Afluria® in the United States beginning with the 2010-2011 influenza season. The manufacture, filling and packaging of Afluria® will continue and will not change with this agreement; CSL Ltd. will retain the Afluria® license.

For information on prebooking Afluria® for the 2010-2011 season, please visit www.merckvaccines.com/afluria or call the Merck Vaccine Customer Center at 877-829-6372.

For any questions relating to Afluria® 2009-2010, please contact 1-888-435-8633 or CustomerSupport@cslbiotherapies.com.

Afluria® 2009-2010 Prescribing Information (Revised 11/2009)

CSL Biotherapies' plans or capacity for manufacturing and delivering its pandemic Influenza A (H1N1) Monovalent Vaccine to US Human Health Services (HHS) are not affected by the seasonal influenza vaccine agreement. For any questions relating to CSL Biotherapies' Influenza A (H1N1) 2009 Monovalent Vaccine, please contact 1-888-435-8633 or CustomerSupport@cslbiotherapies.com.

CSL Biotherapies' Influenza A (H1N1) 2009 Monovalent Vaccine Prescribing Information

Afluria
 

Protect Against the Flu.

Afluria® is a vaccine for influenza manufactured by CSL Biotherapies, a subsidiary of CSL Limited, available in thimerosal-free prefilled syringes and multi-use vials containing thimerosal as a preservative.

Everyone is at risk, but some populations such as people with certain chronic disorders of the pulmonary or cardiovascular systems, including asthma, or any chronic renal, hepatic, hematological, or metabolic disorders,1 are at increased risk of fatal complications caused by the flu.2 Vaccinating caregivers is the right thing to do.

The Flu Is a Serious Illness

Patients need to know
  • Influenza is a serious disease that can be deadly.
  • The flu virus changes every year. That’s why you need to get your flu shot each and every year to help avoid the flu.
  • Some of the people most likely to face the most problems with the flu are:
    • Women who will be pregnant during the influenza season
    • People age 50 or older
    • People with other health problems
  • Vaccinating caregivers is important.

Your Role: Getting the Word Out to Your Patients and Your Community

Influenza is difficult to avoid due to the airborne nature of the virus.2 Higher vaccination coverage should be a priority in every clinical practice. The ACIP also specifically recommends that healthcare providers be vaccinated.1

How do YOU get the word out?

Tell us how you protect your patients from the flu.
Go Now >

When to Vaccinate?

Seasonal influenza outbreaks in the United States, which usually begin in October or November and reach their peak from December to March3.

A Season Ahead

We provide flu vaccine in the southern hemisphere a season ahead.
Go Now >
In the northern hemisphere, vaccination occurs between September and February.2 This allows a patient's immune system to build the necessary volume of antibodies that will combat the virus when it arrives later in the year.2

Vaccination is still recommended in late February for lower-risk populations and must always be considered if the annual peak of epidemics has not yet been reached.2

The United States Department of Health & Human Services expects that by 2010, up to 65% of the population will be vaccinated against influenza annually.2 CSL Biotherapies is committed to helping the United States achieve this standard of care.

 

Healthcare Providers

Protecting yourself from the flu is important.
Go Now >

College Students

College dormitories and the flu.
Go Now >

Caregivers

Recommendations for caregivers.
Go Now >
 

Order Afluria Now

Share with a Colleague